• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:刘玉峰.硝呋太尔-制霉菌素阴道栓治疗细菌性阴道病的疗效及安全性分析[J].中国现代应用药学,2011,28(10):962-965.
LIU Yufeng.Efficacy and Safety of Nifuratel-nysfungin Suppository in the Treatment of Bacterial Vaginosis[J].Chin J Mod Appl Pharm(中国现代应用药学),2011,28(10):962-965.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3436次   下载 2927 本文二维码信息
码上扫一扫!
分享到: 微信 更多
硝呋太尔-制霉菌素阴道栓治疗细菌性阴道病的疗效及安全性分析
刘玉峰
松阳县人民医院,浙江 松阳 323400
摘要:
目的 评价硝呋太尔-制霉菌素阴道栓治疗细菌性阴道病的疗效和安全性。方法 本研究采用随机对照试验。试验组80例,对照组78例,分别给予硝呋太尔-制霉菌素栓和甲硝唑栓,疗程分别为6 d和7 d。分别于停药后3~5 d 和停药后月经来潮干净3~7 d观察疗效和安全性。结果 停药后3~5 d,试验组和对照组有效率分别为90.0%和82.5%,差异无统计学意义(P>0.05),两组间疗效比较无显著差异(P>0.05);停药后月经来潮干净后3~7 d,试验组和对照组有效率分别为82.5%和73.1%,差异无统计学意义(P>0.05),两组疗效无显著差异(P>0.05)。试验中未见严重不良反应,不良反应发生率试验组低于对照组(P<0.05)。结论 硝呋太尔-制霉菌素栓治疗细菌性阴道病安全、有效。
关键词:  阴道病  细菌性  硝呋太尔-制霉菌素栓  甲硝唑栓
DOI:
分类号:
基金项目:
Efficacy and Safety of Nifuratel-nysfungin Suppository in the Treatment of Bacterial Vaginosis
LIU Yufeng
The People’s Hospital of Songyang, Songyang 323400, China
Abstract:
OBJECTIVE To evaluate the efficacy and safety of nifuratel-nysfungin suppository in the treatment of bacterial vaginosis. METHODS A randomized and controlled clinical trial was conducted. The 80 patients in trial group were treated with nifuratel-nysfungin suppository and 78 patients in control group were given metronidazole suppository. Six successive days were taken as a course for nifuratel-nysfungin suppository group and seven successive days for metronidazole suppository. The efficacy and safety were observed respectively 3-5 d after treatment and 3-7 d after menorrhea. RESULTS The efficacy rate was 90.0% in trial group and 82.5% in control group on 3-5 d after treatment (P>0.05). There was no significant difference in clinical efficacy between two groups(P>0.05). The efficacy rate was 82.5% in trial group and 73.1% in control group on 3-7 d after menorrhea (P>0.05). There was no significant difference in clinical efficacy between two groups (P>0.05). No severe adverse reactions were found in the trial. The adverse reactions incidence in trial group was lower than that in control group(P<0.5). CONCLUSION Nifuratel-nysfungin suppository is an effective and safe preparation in the treatment of bacterial vaginosis.
Key words:  vaginosis  bacterial  nifuratel-nysfungin suppository  metronidazole suppository
扫一扫关注本刊微信